{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:34Z","timestamp":1787020474811,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870844"],"award-info":[{"award-number":["31870844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31570851"],"award-info":[{"award-number":["31570851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radioresistance inducing by hypoxic microenvironment of hepatocellular carcinoma is a major obstacle to clinical radiotherapy. Advanced nanomedicine provides an alternative to alleviate the hypoxia extent of solid tumor, even to achieve effective synergistic treatment when combined with chemotherapy or radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, we developed a self-assembled nanoparticle based on hemoglobin and curcumin for photoacoustic imaging and radiotherapy of hypoxic hepatocellular carcinoma. The fabricated nanoparticles inhibited hepatoma migration and vascular mimics, and enhanced the radiosensitivity of hypoxic hepatoma cells in vitro via repressing cell proliferation and DNA damage repair, as well as inducing apoptosis. Benefit from oxygen-carrying hemoglobin combined with polyphenolic curcumin, the nanoparticles also effectively enhanced the photoacoustic contrast and the efficacy of radiotherapy for hepatocellular carcinoma in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, the current study offered a radiosensitization platform for optimizing the efficacy of nanomedicines on hypoxic radioresistant tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-022-01316-w","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:02:43Z","timestamp":1646467363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Ruoling","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7080-0500","authenticated-orcid":false,"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"issue":"6","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1316_CR2","first-page":"69","volume":"61","author":"J Ahmedin","year":"2011","unstructured":"Ahmedin J, Freddie B, Melissa MC, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1316_CR3","first-page":"244","volume":"57","author":"R Wijsman","year":"2013","unstructured":"Wijsman R, Kaanders JH, Oyen WJ, et al. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography. Quart J Nucl Med Mol Imag. 2013;57(3):244\u201356.","journal-title":"Quart J Nucl Med Mol Imag."},{"key":"1316_CR4","doi-asserted-by":"crossref","unstructured":"Petrova V, Annicchiarico-Petruzzelli M, Melino G, et al. The hypoxic tumour microenvironment. Oncogenesis, 2018;7(1).","DOI":"10.1038\/s41389-017-0011-9"},{"issue":"5","key":"1316_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","volume":"8","author":"GL Semenza","year":"1998","unstructured":"Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998;8(5):588\u201394.","journal-title":"Curr Opin Genet Dev"},{"issue":"Suppl 1","key":"1316_CR6","doi-asserted-by":"publisher","first-page":"i99","DOI":"10.1093\/jrr\/rrw012","volume":"57","author":"H Harada","year":"2016","unstructured":"Harada H. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance. J Radiat Res. 2016;57(Suppl 1):i99\u2013105.","journal-title":"J Radiat Res"},{"issue":"1","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0970-9290.131142","volume":"25","author":"J Raviraj","year":"2014","unstructured":"Raviraj J, Bokkasam V, Kumar V, et al. Radiosensitizers, radioprotectors, and radiation mitigators. Indian J Dental Res Off Publ Indian Soc Dental Res. 2014;25(1):83\u201390.","journal-title":"Indian J Dental Res Off Publ Indian Soc Dental Res"},{"key":"1316_CR8","doi-asserted-by":"crossref","unstructured":"Fernndez E, Morillo V, Salvador M, et al. Hyperbaric oxygen and radiation therapy: a review. Clin Transl Oncol. 2020.","DOI":"10.1007\/s12094-020-02513-5"},{"issue":"11","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1185\/03007995.2015.1082988","volume":"31","author":"J Chen","year":"2015","unstructured":"Chen J, Xu H, Ding J, et al. Radiotherapy after hyperbaric oxygenation in malignant gliomas. Curr Med Res Opin. 2015;31(11):1977\u201384.","journal-title":"Curr Med Res Opin"},{"issue":"47","key":"1316_CR10","doi-asserted-by":"publisher","first-page":"14166","DOI":"10.1021\/acs.langmuir.0c01698","volume":"36","author":"R Hickey","year":"2020","unstructured":"Hickey R, Palmer A. Synthesis of hemoglobin-based oxygen carrier nanoparticles by desolvation precipitation. Langmuir ACS J Surf Coll. 2020;36(47):14166\u201372.","journal-title":"Langmuir ACS J Surf Coll"},{"key":"1316_CR11","unstructured":"Gers J, Wrobeln A, Ferenz K. Perfluorocarbon-based oxygen carriers: from physics to physiology. Pflugers Archiv Eur J Physiol. 2020."},{"key":"1316_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.freeradbiomed.2017.01.030","volume":"111","author":"A Gasparovic","year":"2017","unstructured":"Gasparovic A, Milkovic L, Sunjic S, et al. Cancer growth regulation by 4-hydroxynonenal. Free Rad Biol Med. 2017;111:226\u201334.","journal-title":"Free Rad Biol Med"},{"issue":"15","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1042\/CS20160935","volume":"131","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB, Bordoloi D, Harsha C, et al. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci (Lond). 2017;131(15):1781\u201399.","journal-title":"Clin Sci (Lond)"},{"key":"1316_CR14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.xphs.2020.12.011","volume":"110","author":"K Barick","year":"2020","unstructured":"Barick K, Tripathi A, Dutta B, et al. Curcumin encapsulated casein nanoparticles: enhanced bioavailability and anticancer efficacy. J Pharmaceut Sci. 2020;110:2114.","journal-title":"J Pharmaceut Sci"},{"issue":"4","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3892\/ol.2014.2401","volume":"8","author":"L Yiming","year":"2014","unstructured":"Yiming L, Min H, Jianwen L, et al. Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2. Oncol Lett. 2014;8(4):1849\u201355.","journal-title":"Oncol Lett"},{"key":"1316_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.addr.2016.10.002","volume":"109","author":"S Rey","year":"2017","unstructured":"Rey S, Schito L, Koritzinsky M, et al. Molecular targeting of hypoxia in radiotherapy. Adv Drug Deliv Rev. 2017;109:45\u201362.","journal-title":"Adv Drug Deliv Rev"},{"key":"1316_CR17","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","volume":"9","author":"SD Jayasingam","year":"2019","unstructured":"Jayasingam SD, Citartan M, Thang TH, et al. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol. 2019;9:1512.","journal-title":"Front Oncol"},{"issue":"11","key":"1316_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/bjc.2017.356","volume":"117","author":"A Shweta","year":"2017","unstructured":"Shweta A, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017;117(11):1583\u201391.","journal-title":"Br J Cancer"},{"issue":"7446","key":"1316_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445\u201355.","journal-title":"Nature"},{"issue":"1","key":"1316_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","volume":"19","author":"R Charlotte","year":"2011","unstructured":"Charlotte R, Massimiliano M, Sonia T, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell. 2011;19(1):31\u201344.","journal-title":"Cancer Cell"},{"issue":"12","key":"1316_CR21","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.3390\/ma8125486","volume":"8","author":"K Wang","year":"2015","unstructured":"Wang K, Wang J, Hu W, et al. Acid denaturation inducing self-assembly of curcumin-loaded hemoglobin nanoparticles. Materials. 2015;8(12):8701\u201313.","journal-title":"Materials"},{"issue":"7","key":"1316_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00066-011-2248-0","volume":"187","author":"S Mareike","year":"2011","unstructured":"Mareike S, Wolfgang J, Reinhard D. Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft. 2011;187(7):393\u2013400.","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft."},{"key":"1316_CR23","doi-asserted-by":"crossref","unstructured":"Sheeja A, Mohan N, Herman TS, Awasthi V, Aravindan N. Molecular basis of \u2018hypoxic\u2019 breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling. Radiat Oncol. 2013;8(46).","DOI":"10.1186\/1748-717X-8-46"},{"key":"1316_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biopha.2015.12.007","volume":"77","author":"O Berrak","year":"2016","unstructured":"Berrak O, Akkoc Y, Arisan ED, et al. The inhibition of PI3K and NFkappaB promoted curcumin-induced cell cycle arrest at G2\/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells. Biomed Pharmacother. 2016;77:150\u201360.","journal-title":"Biomed Pharmacother"},{"key":"1316_CR25","doi-asserted-by":"crossref","first-page":"5787218","DOI":"10.1155\/2017\/5787218","volume":"2017","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Bu S. Curcumin induces autophagy, apoptosis, and cell cycle arrest in human pancreatic cancer cells. Evid Based Compl Altern Med eCAM. 2017;2017:5787218.","journal-title":"Evid Based Compl Altern Med eCAM"},{"issue":"7","key":"1316_CR26","doi-asserted-by":"publisher","first-page":"10281","DOI":"10.1002\/jcp.27933","volume":"234","author":"A Hesari","year":"2019","unstructured":"Hesari A, Rezaei M, Rezaei M, et al. Effect of curcumin on glioblastoma cells. J Cell Physiol. 2019;234(7):10281\u20138.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1316_CR27","first-page":"1843","volume":"42","author":"L Zhang","year":"2019","unstructured":"Zhang L, Tao X, Fu Q, et al. Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4\/MyD88 and EGFR pathways. Oncol Rep. 2019;42(5):1843\u201355.","journal-title":"Oncol Rep"},{"key":"1316_CR28","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.2147\/OTT.S172909","volume":"12","author":"Y Sun","year":"2019","unstructured":"Sun Y, Liu L, Wang Y, et al. Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2\/p-STAT3 pathway. OncoTargets Ther. 2019;12:2011\u201321.","journal-title":"OncoTargets Ther"},{"issue":"1","key":"1316_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14791\/btrt.2019.7.e28","volume":"7","author":"KS Park","year":"2019","unstructured":"Park KS, Yoon SY, Park SH, et al. Anti-migration and anti-invasion effects of curcumin via suppression of fascin expression in glioblastoma cells. Brain Tumor Res Treat. 2019;7(1):16\u201324.","journal-title":"Brain Tumor Res Treat"},{"issue":"4","key":"1316_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/medicina55040090","volume":"55","author":"SA Hosseini","year":"2019","unstructured":"Hosseini SA, Zand H, Cheraghpour M. The influence of curcumin on the downregulation of MYC, insulin and IGF-1 receptors: a possible mechanism underlying the anti-growth and anti-migration in chemoresistant colorectal cancer cells. Medicina. 2019;55(4):90.","journal-title":"Medicina"},{"issue":"1","key":"1316_CR31","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1186\/s12885-018-5130-y","volume":"18","author":"Y Li","year":"2018","unstructured":"Li Y, Sun W, Han N, et al. Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK\/STAT pathway. BMC Cancer. 2018;18(1):1230.","journal-title":"BMC Cancer"},{"issue":"4","key":"1316_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larrivee B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409\u201326.","journal-title":"Angiogenesis"},{"key":"1316_CR33","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1038\/ncomms13322","volume":"7","author":"SC Williamson","year":"2016","unstructured":"Williamson SC, Metcalf RL, Trapani F, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322.","journal-title":"Nat Commun"},{"key":"1316_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.omtn.2017.11.011","volume":"10","author":"J Guo","year":"2018","unstructured":"Guo J, Cai H, Liu X, et al. Long non-coding RNA LINC00339 stimulates glioma vasculogenic mimicry formation by regulating the miR-539-5p\/TWIST1\/MMPs Axis. Mol Ther Nucleic Acids. 2018;10:170\u201386.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"29","key":"1316_CR35","doi-asserted-by":"publisher","first-page":"47801","DOI":"10.18632\/oncotarget.17999","volume":"8","author":"D-MZ Jianyang","year":"2017","unstructured":"Jianyang D-MZ, Xiao-Gang Z, Yin NI, Zhang YI, Zhang Z-X, Li DC, Zhou J. HIF-2\u03b1 promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VEcadherin promoter. Oncotarget. 2017;8(29):47801.","journal-title":"Oncotarget"},{"key":"1316_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellsig.2019.04.011","volume":"60","author":"W Yang","year":"2019","unstructured":"Yang W, Liu Y, Gao R, et al. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance. Cell Signal. 2019;60:122\u201335.","journal-title":"Cell Signal"},{"issue":"2","key":"1316_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/cbt.11.2.13842","volume":"11","author":"LX Chen","year":"2011","unstructured":"Chen LX, He YJ, Zhao SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2\/PI3K\/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther. 2011;11(2):229\u201335.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"1316_CR38","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3892\/ol.2014.2401","volume":"8","author":"Y Liang","year":"2014","unstructured":"Liang Y, Huang M, Li J, et al. Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2. Oncol Lett. 2014;8(4):1849\u201355.","journal-title":"Oncol Lett"},{"key":"1316_CR39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.biopha.2017.07.148","volume":"94","author":"G Li","year":"2017","unstructured":"Li G, Wang Z, Chong T, et al. Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-kappaB signaling pathway. Biomed Pharmacother. 2017;94:974\u201381.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1316_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3892\/or.2012.2091","volume":"29","author":"Q Qiao","year":"2013","unstructured":"Qiao Q, Jiang Y, Li G. Curcumin enhances the response of non-Hodgkin\u2019s lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2\/M phase and inhibition of mTOR phosphorylation. Oncol Rep. 2013;29(1):380\u20136.","journal-title":"Oncol Rep"},{"issue":"8","key":"1316_CR41","doi-asserted-by":"publisher","first-page":"e0222130","DOI":"10.1371\/journal.pone.0222130","volume":"14","author":"PO Editors","year":"2019","unstructured":"Editors PO. Retraction: curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-kappaB activity. PLoS ONE. 2019;14(8):e0222130.","journal-title":"PLoS ONE"},{"issue":"4","key":"1316_CR42","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3892\/or.2014.3009","volume":"31","author":"IT Chiang","year":"2014","unstructured":"Chiang IT, Liu YC, Hsu FT, et al. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-kappaB activity. Oncol Rep. 2014;31(4):1729\u201337.","journal-title":"Oncol Rep"},{"issue":"1","key":"1316_CR43","first-page":"131","volume":"38","author":"G Yang","year":"2018","unstructured":"Yang G, Qiu J, Wang D, et al. Traditional Chinese medicine curcumin sensitizes human colon cancer to radiation by altering the expression of DNA repair-related genes. Anticancer Res. 2018;38(1):131\u20136.","journal-title":"Anticancer Res"},{"issue":"3","key":"1316_CR44","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jcp.25961","volume":"233","author":"A Tajbakhsh","year":"2018","unstructured":"Tajbakhsh A, Hasanzadeh M, Rezaee M, et al. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways. J Cell Physiol. 2018;233(3):2183\u201392.","journal-title":"J Cell Physiol"},{"issue":"14","key":"1316_CR45","doi-asserted-by":"publisher","first-page":"1707140","DOI":"10.1002\/adfm.201707140","volume":"28","author":"H Xu","year":"2018","unstructured":"Xu H, Wang T, Yang C, et al. Supramolecular nanofibers of curcumin for highly amplified radiosensitization of colorectal cancers to ionizing radiation. Adv Func Mater. 2018;28(14):1707140.","journal-title":"Adv Func Mater"},{"issue":"11","key":"1316_CR46","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/carcin\/bgt240","volume":"34","author":"H Ogiwara","year":"2013","unstructured":"Ogiwara H, Ui A, Shiotani B, et al. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor. Carcinogenesis. 2013;34(11):2486\u201397.","journal-title":"Carcinogenesis"},{"issue":"8","key":"1316_CR47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/09553002.2014.916841","volume":"90","author":"C Peitzsch","year":"2014","unstructured":"Peitzsch C, Perrin R, Hill RP, et al. Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol. 2014;90(8):636\u201352.","journal-title":"Int J Radiat Biol"},{"issue":"5","key":"1316_CR48","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1039\/C9NR09071A","volume":"12","author":"Z Lirong","year":"2020","unstructured":"Lirong Z, Changhui F, Longfei T, et al. Advanced nanotechnology for hypoxia-associated antitumor therapy. Nanoscale. 2020;12(5):2855\u201374.","journal-title":"Nanoscale"},{"issue":"3","key":"1316_CR49","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3892\/or.2015.4092","volume":"34","author":"H Chia-Chi","year":"2015","unstructured":"Chia-Chi H, Ling-Chia W, Cheng-Yuan H, et al. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs. Oncol Rep. 2015;34(3):1620\u20138.","journal-title":"Oncol Rep"},{"key":"1316_CR50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.actbio.2018.09.017","volume":"80","author":"H Zuo","year":"2018","unstructured":"Zuo H, Tao J, Shi H, et al. Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy. Acta Biomater. 2018;80:296\u2013307.","journal-title":"Acta Biomater"},{"key":"1316_CR51","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.2147\/IJN.S128802","volume":"12","author":"W Li","year":"2017","unstructured":"Li W, Li X, Liu S, et al. Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial\u2013mesenchymal transition inhibition. Int J Nanomed. 2017;12:3509\u201320.","journal-title":"Int J Nanomed"},{"issue":"50","key":"1316_CR52","doi-asserted-by":"publisher","first-page":"46536","DOI":"10.1021\/acsami.9b16837","volume":"11","author":"C Zhu","year":"2019","unstructured":"Zhu C, Guo X, Luo L, et al. Extremely effective chemoradiotherapy by inducing immunogenic cell death and radio-triggered drug release under hypoxia alleviation. ACS Appl Mater Interfaces. 2019;11(50):46536\u201347.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1316_CR53","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1080\/10717544.2019.1693706","volume":"26","author":"X Yuan","year":"2019","unstructured":"Yuan X, Yin Y, Zan W, et al. Hybrid manganese dioxide-bovine serum albumin nanostructure incorporated with doxorubicin and IR780 for enhanced breast cancer chemo-photothermal therapy. Drug Deliv. 2019;26(1):1254\u201364.","journal-title":"Drug Deliv"},{"key":"1316_CR54","doi-asserted-by":"publisher","first-page":"202001","DOI":"10.1088\/1361-6528\/ab6fe1","volume":"31","author":"Y Chen","year":"2020","unstructured":"Chen Y, Cong H, Shen Y, et al. Biomedical application of manganese dioxide nanomaterials. Nanotechnology. 2020;31:202001.","journal-title":"Nanotechnology"},{"issue":"1","key":"1316_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1021\/acsnano.5b06779","volume":"10","author":"M Song","year":"2016","unstructured":"Song M, Liu T, Shi C, et al. Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia. ACS Nano. 2016;10(1):633\u201347.","journal-title":"ACS Nano"},{"issue":"1","key":"1316_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/molecules24010009","volume":"24","author":"FJ Van Dalen","year":"2018","unstructured":"Van Dalen FJ, Van Stevendaal MHME, Fennemann FL, et al. Molecular repolarisation of tumour-associated macrophages. Molecules (Basel, Switzerland). 2018;24(1):9.","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"1316_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","volume":"106","author":"W Lx","year":"2019","unstructured":"Lx W, Sx Z, Hj W, et al. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2019;106(2):345\u201358.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"1316_CR58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunol. 2010;11(10):889\u201396.","journal-title":"Nature Immunol"},{"issue":"29","key":"1316_CR59","doi-asserted-by":"publisher","first-page":"48436","DOI":"10.18632\/oncotarget.17061","volume":"8","author":"Z Xiang","year":"2017","unstructured":"Xiang Z, Kati T, Javier M, et al. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. Oncotarget. 2017;8(29):48436\u201352.","journal-title":"Oncotarget"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01316-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:32:46Z","timestamp":1726763566000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01316-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01316-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}